STOCK TITAN

AMERICAN VANGUARD CORP (AVD) SEC Filings, Aug 8-19, 2025

AVD NYSE

Welcome to our dedicated page for AMERICAN VANGUARD SEC filings (Ticker: AVD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

American Vanguard Corporation's SEC filings document the formal disclosures of a NYSE-listed specialty agriculture products company and its AMVAC Chemical Corporation operating subsidiary. Recent Form 8-K reports cover operating results, earnings-call materials, Regulation FD disclosures and material credit arrangements, including term-loan and revolving-credit amendments tied to the company's capital structure and working-capital needs.

Proxy and annual-meeting filings address board elections, director composition, auditor ratification, executive compensation and shareholder voting matters. The filings also identify the company's common stock, par value, exchange listing and governance actions related to board size and committee-level oversight.

Rhea-AI Summary

American Vanguard Corporation filed a Current Report on Form 8-K disclosing an Amendment Number Twelve to the Third Amended and Restated Loan and Security Agreement dated August 18, 2025, involving the registrant, AMVAC Chemical Corporation, certain direct and indirect subsidiaries, and the senior lending group parties. The filing references a press release dated August 19, 2025 and includes an interactive Inline XBRL cover page data file. The report is signed by Timothy J. Donnelly, Chief Information Officer, General Counsel & Secretary. The document does not include the economic terms or covenant changes of the amendment within the provided text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
current report
-
Rhea-AI Summary

Keith M. Rosenbloom, a director of American Vanguard Corporation (AVD), reported an acquisition on 08/07/2025 of 17,621 deferred stock units (DSUs) awarded under the company’s non-management director compensation program. Each DSU represents the right to one share of common stock upon settlement when the recipient’s service ends; DSUs are nontransferable and do not carry voting or dividend rights during service. Following the award, Mr. Rosenbloom reports 34,411 shares beneficially owned directly and an indirect interest in 789,284 shares held by funds and separately managed accounts advised by Cruiser Capital, where he is Managing Member. The Form 4 was signed on 08/14/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

American Vanguard Corp (AVD) amended an insider Form 4 to correct previously reported holdings and explain changes in advisory authority. The filing discloses a disposition of 16,790 shares and states that a client of a separately managed account terminated its advisory agreement, removing Cruiser Capital's discretionary voting and dispositive authority over 411,398 shares; the termination involved no buy or sell transactions. The amendment corrects an earlier misstatement that reported 652,792 indirectly held shares; the filing clarifies the correct indirect holding is 789,284 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Mark R. Bassett, a director of American Vanguard Corporation (AVD), reported the award of 17,621 deferred stock units (DSUs) on 08/07/2025 as part of the company’s non-management director compensation program. The DSUs are granted at $0, are nontransferable during the recipient’s service, and represent the right to receive one share of common stock upon settlement when the recipient’s service ends.

Following the award, the form shows 34,411 shares/units beneficially owned by the reporting person. No derivative securities were reported and the filing was submitted as an individual Form 4 by the director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Carmen Tiu de Mino, a director of American Vanguard Corporation (AVD), was awarded 17,621 deferred stock units on 08/07/2025 as part of the company's non-management director compensation program. Each deferred stock unit (DSU) entitles the holder to one share upon settlement when the recipient's service with the company ends; DSUs are nontransferable and carry neither voting nor dividend rights during the remaining term of service.

Following the award, the reporting person beneficially owned 24,407 shares on a direct basis. The DSUs were issued at a recorded price of $0 and are subject to the company's standard DSU agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marisol Angelini, a director of American Vanguard Corp (AVD), reported on Form 4 that she was awarded 17,621 shares of common stock on 08/07/2025 as part of the companys compensation program for non-management directors related to the 2025 annual stockholders meeting. The award is reported at a price of $0 in the filing and is explained in an accompanying footnote.

Following the award, Angelini beneficially owns 36,890 shares. The Form 4 was signed on 08/08/2025 and filed by one reporting person. No derivative transactions are listed in Table II.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Gunter Emer, a director of American Vanguard Corporation (AVD), reported receiving 8,810 shares of common stock on 08/07/2025 as part of the company’s non-management director compensation program. The award was issued at $0 and increased his direct beneficial ownership to 33,723 shares.

The Form 4 shows no derivative securities and records the filing signature on 08/08/2025. The disclosure reflects a routine director equity award tied to the 2025 annual stockholders’ meeting rather than a market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

American Vanguard Corporation director Steven D. Macicek was awarded 17,621 deferred stock units (DSUs) on 08/07/2025 as part of the companys non-management director compensation program tied to the 2025 annual stockholders meeting. Each DSU represents the right to receive one share of common stock upon settlement.

The DSUs were granted at $0, are nontransferable during the recipients service, and carry no voting or dividend rights until settlement. Following the award the reporting persons beneficial ownership is reported as 48,839 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

American Vanguard Corporation (AVD) reported that director Scott Baskin was awarded 8,810 shares of common stock on 08/07/2025 as part of the company’s non-management director compensation program. The shares were granted at a price of $0, reflecting an award rather than an open-market purchase.

Following the grant, Mr. Baskin’s reported beneficial ownership increased to 41,997 shares. The filing identifies Mr. Baskin as a director and notes the award was connected to the 2025 annual stockholders' meeting. This is a routine equity award disclosed on Form 4 and does not include additional transactions or derivative positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Patrick E. Gottschalk, a director of American Vanguard Corporation (AVD), was awarded 17,621 deferred stock units (DSUs) on 08/07/2025 as part of the companys non-management director compensation program. Each DSU represents the right to receive one share of common stock upon settlement when the recipients service with the company ends; while outstanding the DSUs are nontransferable and carry neither voting nor dividend rights.

Following the award, Gottschalks reported beneficial ownership of AVD common stock is 79,424 shares (direct). The DSUs were granted at a reported price of $0 and are subject to the companys standard DSU agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many AMERICAN VANGUARD (AVD) SEC filings are available on StockTitan?

StockTitan tracks 55 SEC filings for AMERICAN VANGUARD (AVD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AMERICAN VANGUARD (AVD)?

The most recent SEC filing for AMERICAN VANGUARD (AVD) was filed on August 19, 2025.